- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1435-5922
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Microbial biomarkers for immune checkpoint blockade therapy against cancer ; volume:53 ; number:9 ; day:12 ; month:7 ; year:2018 ; pages:999-1005 ; date:9.2018
Journal of gastroenterology ; 53, Heft 9 (12.7.2018), 999-1005, 9.2018
- Urheber
-
Adachi, Keishi
- Beteiligte Personen und Organisationen
-
Tamada, Koji
SpringerLink (Online service)
- DOI
-
10.1007/s00535-018-1492-9
- URN
-
urn:nbn:de:101:1-2018101904352763156254
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Adachi, Keishi
- Tamada, Koji
- SpringerLink (Online service)
Ähnliche Objekte (12)
A gut microbial signature for combination immune checkpoint blockade across cancer types
Immune checkpoint blockade in ovarian cancer
Smoldering myocarditis following immune checkpoint blockade
Activation of phagocytosis by immune checkpoint blockade
Immune checkpoint inhibitors: recent progress and potential biomarkers
Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients: a pilot study
Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer
Blood-based biomarkers in patients with non-small cell lung cancer treated with immune checkpoint blockade
The Role of Immune Checkpoint Blockade in Uveal Melanoma
The role of neoantigen in immune checkpoint blockade therapy
Regulatory T cells in immune checkpoint blockade antitumor therapy
Prospects for combining immune checkpoint blockade with PARP inhibition
A gut microbial signature for combination immune checkpoint blockade across cancer types
Immune checkpoint blockade in ovarian cancer
Smoldering myocarditis following immune checkpoint blockade
Activation of phagocytosis by immune checkpoint blockade
Immune checkpoint inhibitors: recent progress and potential biomarkers
Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients: a pilot study
Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer
Blood-based biomarkers in patients with non-small cell lung cancer treated with immune checkpoint blockade
The Role of Immune Checkpoint Blockade in Uveal Melanoma
The role of neoantigen in immune checkpoint blockade therapy
Regulatory T cells in immune checkpoint blockade antitumor therapy
Prospects for combining immune checkpoint blockade with PARP inhibition
A gut microbial signature for combination immune checkpoint blockade across cancer types
Immune checkpoint blockade in ovarian cancer
Smoldering myocarditis following immune checkpoint blockade
Activation of phagocytosis by immune checkpoint blockade
Immune checkpoint inhibitors: recent progress and potential biomarkers
Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients: a pilot study
Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer
Blood-based biomarkers in patients with non-small cell lung cancer treated with immune checkpoint blockade
The Role of Immune Checkpoint Blockade in Uveal Melanoma
The role of neoantigen in immune checkpoint blockade therapy
Regulatory T cells in immune checkpoint blockade antitumor therapy